Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ilaprazole-based Quadruple Therapy for H. pylori Eradication
NCT02835560Phase 4Completed
- Sponsor
- Livzon Pharmaceutical Group Inc.
- Start
- Jun 2013
- Primary completion
- Jul 2015
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of ilaprazole in Helicobacter pylori infection, sponsored by Livzon Pharmaceutical Group Inc.. Started Jun 2013; status: completed.
02
Drugs
ilaprazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT02835560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02835560.